REFERENCES
1. Okabayashi K., Ashrafi an H., Zacharakis E., Hasegawa H., Kitagawa Y., Athanasiou T., et al. Adhesions after abdominal surgery: a systematic review of the incidence, distribution and severity. Surg Today. 2014; 44: 405–20.
2. Coccolini F., Ansaloni L., Manfredi R., et al. Peritoneal adhesion index (PAI): proposal of a score for the «ignored iceberg» of medicine and surgery. World J Emerg Surg. 2013; 8 (1): 6. DOI: https://doi.org/10.1186/1749-7922-8-6
3. De Wilde R.L., Brolmann H., Koninckx P.R., et al. Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecol Surg. 2012; 9 (4): 365-8. DOI: https://doi.org/10.1007/s10397-012-0764-2
4. Ray N.F., Denton W.G., Thamer M., Henderson S.C., Perry S. Abdominal adhe-siolysis: inpatient care and expenditures in the United States in 1994. J Am Coll Surg. 1998; 186 (1): 1-9. DOI: https://doi.org/10.1016/s1072-7515(97)00127-0
5. De Wilde R.L., Brolmann H., Koninckx P.R., et al. Prevention of adhesions in gynaecological surgery: the 2012 European field guideline. Gynecol Surg. 2012; 9 (4): 365-8. DOI: https://doi.org/10.1007/s10397-012-0764-2
6. Lutsevich O.E., Akimov V.P., Shirinsky V.G., Bichev A.A. Adhesive disease of the peritoneum: a modern view of pathogenesis and treatment. Khirurgiya. Zhurnal imeni N.I. Pirogova [Surgery. The Journal Named after N.I. Pirogov]. 2017; (10): 100-8. DOI: https://doi.org/10.17116/hirurgia201710100-108 (in Russian)
7. Kovacs E.J., DiPietro L.A. Fibrogenic cytokines and connective tissue production. FASEB J. 1994; 8 (11): 854-61. DOI: https://doi.org/10.1096/fasebj.8.11.7520879
8. Zeyneloglu H.B., Senturk L.M., Seli E., et al. The role of monocyte chemotactic protein-1 in intraperitoneal adhesion formation. Hum Reprod. 1998; 13 (5): 1194-9. DOI: https://doi.org/10.1093/humrep/13.5.1194
9. Kovacs E.J. Fibrogenic cytokines: the role of immune mediators in the development of scar tissue. Immunol Today. 1991; 12 (1): 17-23. DOI: https://doi.org/10.1016/0167-5699(91)90107-5
10. Fernandez H., Benifla J.L., Fritel X., et al. Post-curettage and aspiration syn-echiae: is there value in an anti-adhesion agent? J Gynecol Obstet Biol Reprod (Paris). 2012; 41 (2): 8-12.
11. Snimshchikova I.A., Medvedev A.I., Khalilov M.A., et. al. Theoretical and clinical aspects of excessive adhesion. Vestnik RGMU [Bulletin of RSMU]. 2008; 4: 99-102. (in Russian)
12. Oosterlynck D.J., Lacquet F.A., Waer M., Koninckx P.R. Lymphokinactivated killer activity in women with endometriosis. Gynecol Obstet Invest. 1994; 37 (3): 18590. DOI: https://doi.org/10.1159/000292556
13. Burlev V.A., Dubinskaya E.D., Gasparov A.S., Ilyasova N.A. Antiangiogenic therapy and adhesions in the small pelvis: prospects for prevention and treatment. Rossiyskiy vestnik akushera-ginekologa [Russian Bulletin of Obstetrician-Gynecologist]. 2010; 10 (4): 25-31. (in Russian)
14. Tabibian N., Swehli E., Boyd A., et al. Abdominal adhesions: A practical review of an often overlooked entity. Ann Med Surg (Lond). 2017; 15: 9-13. DOI: https://doi.org/10.1016/j.amsu.2017.01.021
15. Sabry D., Mostafa A., Mekawey D., et al. An experimental model: intrauterine adhesion versus subendometrial fibrosis. Biomed Res. 2018; 29 (17): 3311-8.
16. Fritsch H. Ein Fall von volligen Schwund der Gebaumutterhohle nach Auskratzung. Zentralbl Gynaekol. 1894; 18: 1337-42.
17. Asherman J.G. Traumatic intra-uterine adhesions. J Obstet Gynaecol Br Emp. 1948; 57 (6): 892-96.
18. Yu D., Wong Y.M., Cheong Y., Xia E., Li T.C. Asherman syndrome-one century later. Fertil Steril. 2008; 89: 759-79.
19. Lin S., Xie X., Guo Y., Zhang H., Liu C., Yi J., et al. Clinical characteristics and pregnancy outcomes of infertile patients with endometriosis and endometrial polyps: a retrospective cohort study. Taiwan J Obstet Gynecol. 2020; 59: 916-21.
20. Owusu-Akyaw A., Krishnamoorthy K., Goldsmith L.T., Morelli S.S. The role of mesenchymal-epithelial transition in endometrial function. Hum Reprod Update. 2019; 25: 114-33.
21. Yu D., Wong Y.M., Cheong Y., Xia E., Li T.C. Asherman syndrome-one century later. Fertil Steril. 2008; 89: 759-79.
22. March C.M. Asherman’s syndrome. Semin Reprod Med. 2011; 29 (2): 83-94.
23. Diegelmann R.F., Evans M.C. Wound healing: an overview of acute, fibrotic and delayed healing. Front Biosci. 2004; 9: 283-9.
24. Chen J.X., Yi X.J., Gu P.L., Gao S.X. The role of KDR in intrauterine adhesions may involve the TGF-01/Smads signaling pathway. Braz J Med Biol Res. 2019; 52 (10): e8324.
25. Li J., Cen B., Chen S., He Y. MicroRNA-29b inhibits TGF-p1- induced fibrosis via regulation of the TGF-01/Smad pathway in primary human endometrial stromal cells. Mol Med Rep. 2016; 13 (5): 4229-37.
26. Van Beek J.P., Kennedy L., Rockel J.S., Bernier S.M., Leask A. The induction of CCN2 by TGFp1 involves Ets-1. Arthritis Res Ther. 2006; 8 (2): R36.
27. Evans J., Salamonsen L.A., Winship A., Menkhorst E., Nie G., Gargett C.E., et al. Fertile ground: Human endometrial programming and lessons in health and disease. Nat Rev Endocrinol. 2016; 12: 654-67.
28. Zhou Q., Shi X., Saravelos S., Huang X., Zhao Y., Huang R., et al. Auto-cross-linked hyaluronic acid gel for prevention of intrauterine adhesions after hysteroscopic adhe-siolysis: a randomized controlled trial. J Minim Invasive Gynecol. 2021; 28: 307-13.
29. Lin X., Wei M., Li T.C., Huang Q., Huang D., Zhou F., et al. A comparison of intrauterine balloon, intrauterine contraceptive device and hyaluronic acid gel in the prevention of adhesion reformation following hysteroscopic surgery for Asherman syndrome: a cohort study. Eur J Obstet Gynecol Reprod Biol. 2013; 170: 512-6.
30. Zhu R., Duan H., Gan L., Wang S. Comparison of intrauterine suitable balloon and Foley balloon in the prevention of adhesion after hysteroscopic adhesiolysis. Biomed Res Int. 2018; 2018: 9494101.
31. Lee W.L., Lee F.K., Wang P.H. Application of hyaluronic acid in patients with interstitial cystitis. J Chin Med Assoc. 2021; 84: 341-3.
32. Friedman J.A., Wong J.M.K., Chaudhari A., Tsai S., Milad M.P. Hysteroscopic myomectomy: a comparison of techniques and review of current evidence in the management of abnormal uterine bleeding. Curr Opin Obstet Gynecol. 2018; 30: 243-51.
33. Annes J.P., Munger J.S., Rifkin D.B. Making sense of latent TGF-beta activation. J Cell Sci. 2003; 116 (2): 217-24.
34. Handbook of drugs radar. Antiadhesion gel protivoraketnyi absorbable sterile, 2021 [updated 03.10.2021; quoted 29.10.2021]. URL: http://www.rlsnet.ru/pcr_tn_id_81752.htm (in Russian)]
35. Kim T., Ahn K.H., Choi D.S., et al. A randomized, multi-center, clinical trial to assess the efficacy and safety of alginate carboxymethylcellulose hyaluronic acid compared to carboxymethylcellulose hyaluronic acid to prevent postoperative intrauterine adhesion. J Minim Invasive Gynecol. 2012; 19: 731-6.